Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry


Creative Commons License

Camm A. J., Accetta G., Al Mahmeed W., Ambrosio G., Goldhaber S. Z., Haas S., ...Daha Fazla

BMJ OPEN, cilt.7, sa.3, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

Özet

Objectives: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) explored the impact of gender, risk factors and anticoagulant (AC) treatment on 1-year outcomes in patients with nonvalvular atrial fibrillation (NVAF).